These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8155585)

  • 1. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
    HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient dosimetry for 131I-lipiodol therapy.
    Monsieurs MA; Bacher K; Brans B; Vral A; De Ridder L; Dierckx RA; Thierens HM
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):554-61. PubMed ID: 12690415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry.
    Risse JH; Pauleit D; Palmedo H; Bender H; Bucerius J; Ezziddin S; Klein V; Grünwald F; Biersack HJ; Reichmann K
    Nuklearmedizin; 2007; 46(5):192-7. PubMed ID: 17938753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
    Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
    Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
    Lo JG; Wang AY; Wei YY; Lui WY; Chi CW; Chan WK
    Int J Rad Appl Instrum A; 1992 Dec; 43(12):1431-5. PubMed ID: 1334953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract]   [Full Text] [Related]  

  • 9. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of recurrent primary liver cancer using 131I-lipiodol.
    Novell R; Hilson A; Hobbs K
    Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I lipiodol therapy for unresectable hepatocellular carcinoma.
    Rindani RB; Hugh TJ; Roche J; Roach PJ; Smith RC
    ANZ J Surg; 2002 Mar; 72(3):210-4. PubMed ID: 12071454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
    Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
    Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
    Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J
    Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
    Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
    Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
    Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.